65 investors urge drugmakers to tie bonuses to vaccine equity

A group of 65 investment firms are urging drug companies to include global COVID-19 vaccine equity targets as part of their executive compensation policies.

Advertisement

The firms, which control nearly $3.5 trillion in assets worldwide, include asset managers, pension funds and insurers.

“What we’re asking the companies to do is to tie their remuneration policy and strategy to a more equitable distribution of the vaccine,” Rogier Krens, chief investment officer of Achmea Investment Management, told BBC News.

If drug companies fail to improve vaccine distribution, executive bonuses could be withheld, Mr. Krens said.

View the full article here.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.